Cargando…
Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052925/ https://www.ncbi.nlm.nih.gov/pubmed/35142155 http://dx.doi.org/10.3324/haematol.2021.280516 |
_version_ | 1784696887139368960 |
---|---|
author | Gangat, Naseema Oliveira, Jennifer L. Porter, Tavanna R Hoyer, James D. Al-Kali, Aref Patnaik, Mrinal M Pardanani, Animesh Tefferi, Ayalew |
author_facet | Gangat, Naseema Oliveira, Jennifer L. Porter, Tavanna R Hoyer, James D. Al-Kali, Aref Patnaik, Mrinal M Pardanani, Animesh Tefferi, Ayalew |
author_sort | Gangat, Naseema |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9052925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-90529252022-05-13 Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience Gangat, Naseema Oliveira, Jennifer L. Porter, Tavanna R Hoyer, James D. Al-Kali, Aref Patnaik, Mrinal M Pardanani, Animesh Tefferi, Ayalew Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-02-10 /pmc/articles/PMC9052925/ /pubmed/35142155 http://dx.doi.org/10.3324/haematol.2021.280516 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letters to the Editor Gangat, Naseema Oliveira, Jennifer L. Porter, Tavanna R Hoyer, James D. Al-Kali, Aref Patnaik, Mrinal M Pardanani, Animesh Tefferi, Ayalew Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience |
title | Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience |
title_full | Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience |
title_fullStr | Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience |
title_full_unstemmed | Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience |
title_short | Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience |
title_sort | erythrocytosis associated with epas1(hif2a), egln1(phd2), vhl, epor or bpgm mutations: the mayo clinic experience |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052925/ https://www.ncbi.nlm.nih.gov/pubmed/35142155 http://dx.doi.org/10.3324/haematol.2021.280516 |
work_keys_str_mv | AT gangatnaseema erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT oliveirajenniferl erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT portertavannar erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT hoyerjamesd erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT alkaliaref erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT patnaikmrinalm erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT pardananianimesh erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience AT tefferiayalew erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience |